The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy by Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M

Get full text

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. by Byrd, J, Brown, JR, O'Brien, S, Barrientos, J, Kay, N, Reddy, N, Coutre, S, Tam, C, Mulligan, S, Jaeger, U, Devereux, S, Barr, P, Furman, R, Kipps, T, Cymbalista, F, Pocock, C, Thornton, P, Caligaris-Cappio, F, Robak, T, Delgado, J, Schuster, S, Montillo, M, Schuh, A, de Vos, S, Gill, D

STEPS TOWARD DETERMINATION OF THE SIZE AND STRUCTURE OF THE BROAD-LINE REGION IN ACTIVE GALACTIC NUCLEI .8. AN INTENSIVE HST, IUE, AND GROUND-BASED STUDY OF NGC-5548 by Korista, K, Alloin, D, Barr, P, Clavel, J, Cohen, R, Crenshaw, D, Evans, I, Horne, K, Koratkar, A, Kriss, G, Krolik, J, Malkan, M, Morris, S, Netzer, H, Obrien, P, Peterson, B, Reichert, G, Rodriguezpascual, P, Wamsteker, W, Anderson, K, Axon, D, Benitez, E, Berlind, P, Bertram, R, Blackwell, J